NCT05507203Phase 3Completed

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Study sponsor: Abivax S.A. · ABVX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-06-24Actual
Enrollment · participants639Actual
Source updated2026-09-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of subjects who achieve clinical remission per Modified Mayo Score at week 8. After: Measure: Proportion of Subjects Who Achieve Clinical Remission Per Modified Mayo Score at Week 8.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview